Triple Giving November OMF logo

 TRIPLE YOUR IMPACT during Triple Giving November | All Donations to OMF are TRIPLED through December 3

Search
Close this search box.

Preprint: A Network Medicine Approach to Investigating ME/CFS Pathogenesis in Severely Ill Patients: A Pilot Study

The Heart of the Matter

  • OMF’s Computational Research Center and the ME/CFS Collaborative Center at Stanford University have released a preprint of their work investigating the pathogenesis of ME/CFS using data from the severely ill patient study (SIPS). 
  • Using a network medicine approach, the team created a SIPS disease module that showed strong interplay with immune and neurological conditions and included a significant presence of genes associated with fatigue and cognitive disorders. 
  • The SIPS disease module showed overlap with two other ME/CFS cohorts, indicating a potential genetic contribution to ME/CFS pathogenesis across cohorts.
  • The modified metabolic networks indicate that an altered immune system response and oxidative stress contribute to the pathophysiology of ME/CFS.
On the left is a picture of Dr. Ron Davis, who has white hair, glasses, and a beard, and is smiling while wearing a light blue shirt. On the right is a picture of Dr. Wenzhong Xiao, who has black hair and is wearing a dark suit jacket over a light-colored shirt.

A Network Medicine Approach to Investigating ME/CFS Pathogenesis in Severely Ill Patients: A Pilot Study

Open Medicine Foundation’s Computational Research Center and the ME/CFS Collaborative Center at Stanford University have released a preprint of their work studying the pathogenesis of ME/CFS in severely ill patients. The severely ill patient study (SIPS) included 20 patients exhibiting severe symptoms of ME/CFS, and this particular research approach utilized whole genome sequencing on blood samples from the project.

This study uses a network medicine approach to identify potential genetic contributions to the mechanisms of ME/CFS. In this kind of approach, a disease module is a way of describing the genes and pathways that are causing problems in patients with that disease. These disease modules are fit into the human PPI network, which is a holistic picture of protein-protein interactions (PPI) in the body, and can therefore be compared or connected to disease modules of other similar diseases. One benefit of a computational, network medicine approach like this is the ability to pull together information from different sources to identify commonalities that may help explain complex problems.

The SIPS disease module was developed from an initial set of 103 pathogenic or likely pathogenic variants identified from the whole genome sequencing. After exploring the connections between relevant genes and symptoms of ME/CFS, the team identified a significant presence of genes associated with fatigue and cognitive disorders – genes related to fatigue were enriched 3.94-fold, and those connected to cognitive disorders were enriched 2.29-fold. 

In addition, when looking at the interplay of the SIPS disease module and other disease modules, there was notable interaction with six neurodegenerative disease pathways. Overall, the most similar diseases identified through this network medicine approach were immune and neurological conditions. These findings match the results of disparate studies, providing strong evidence to support data that is otherwise siloed and helping to develop a cohesive hypothesis for the development of ME/CFS.

To further investigate the pathogenesis of ME/CFS, the study team then cross-referenced the SIPS disease module with two other datasets, containing two ME/CFS cohort disease modules and one disease module for a depressive disorder cohort. The SIPS disease module has about 40% overlap with the other ME/CFS cohorts, but minimal overlap with the depressive disorder cohort. This suggests there might be shared genetic factors that contribute to the development of ME/CFS across cohorts and provides further evidence that conflating ME/CFS with depression is incorrect.

Finally, the study team extended these results by identifying individual pathways that may contribute to the development of ME/CFS. The top pathways they identified align with findings from various studies, which ultimately provides strong evidence that immune dysregulation is part of the pathogenesis of ME/CFS.

Read the full preprint here.

Help support important research initiatives like this!
Your donations of any amount advance our mission to end ME/CFS and Long COVID. 

Open Medicine Foundation also accepts gifts of stock, cryptocurrency, real estate and retirement assets. Learn more today!

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669